Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and PrognosisYvonne Ziegler, Ann M. Nardulli, James J. Moresco et al.|PLoS ONE|2016Cited by 52
Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and TreatmentYvonne Ziegler, Ann M. Nardulli, James J. Moresco et al.|PLoS ONE|2014Cited by 49
Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypesYvonne Ziegler, Ann M. Nardulli, James J. Moresco et al.|Clinical Proteomics|2018Cited by 11
MOESM1 of Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypesYvonne Ziegler, Ann M. Nardulli, John R. Yates et al.|Figshare|2018Cited by 0
JAK/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4/6Yvonne Ziegler, Benita S. Katzenellenbogen|npj Breast Cancer|2026Cited by 0